Suven Pharmaceuticals has informed that the Board of Directors of the Company have been informed by its Promoter, Jasti Property and Equity Holdings (in its capacity as sole trustee of Jasti Family Trust), that they have executed a Share Purchase Agreement with Berhyanda, a Cyprus based company on December 26, 2022. The company has attached Press Release of the acquirer. This intimation is also being uploaded on the Company’s website at www.suvenpharm.com.
The above information is a part of company’s filings submitted to BSE.
